FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285740371> ?p ?o ?g. }

• W4285740371 endingPage "6" @default.
• W4285740371 startingPage "1" @default.
• W4285740371 abstract "To assess the efficacy of apatinib plus S-1 therapy in the treatment of advanced gastric cancer patients and the effect on the levels of tumor markers and Th1 and Th2-like cytokines.From October 2019 to December 2020, 100 patients with advanced gastric cancer assessed for eligibility were recruited and assigned at a ratio of 1 : 1 to receive either S-1 regimen (tegafur, gimeracil, and oteracil potassium capsules) (observation group) or apatinib plus S-1 therapy (experimental group). Outcome measures included clinical efficacy serum tumor marker levels, Th1 and Th2-like cytokine levels, time to progression (TTP), overall survival (OS), and adverse events.The S-1 therapy plus apatinib was associated with a significantly higher efficacy versus S-1 therapy alone (P < 0.05). The eligible patients given S-1 therapy plus apatinib showed significantly lower levels of serum carcinoembryonic antigen (CEA), glycoantigen 199 (CA199), and glycoantigen 125 (CA125) versus those receiving S-1 therapy (P < 0.05). S-1 therapy plus apatinib outperformed the single therapy of S-1 therapy in mitigating the levels of interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), interleukin-4 (IL-4), and interleukin-10 (IL-10) (P < 0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (P > 0.05). S-1 therapy plus apatinib was associated with a significantly shorter TTP (5.2 ± 0.7 months) and a longer OS (9.3 ± 2.5 months) versus S-1 therapy alone (7.1 ± 1.3, 5.1 ± 1.3 months) (P < 0.05).The efficacy of apatinib plus S-1 therapy showed better improvement in lowering the serum tumor marker levels and ameliorating the Th1 and Th2-like cytokine levels versus S-1 therapy alone, so it is worthy of clinical application." @default.
• W4285740371 created "2022-07-18" @default.
• W4285740371 creator A5007068219 @default.
• W4285740371 creator A5017369696 @default.
• W4285740371 creator A5018622165 @default.
• W4285740371 creator A5030560925 @default.
• W4285740371 creator A5060750274 @default.
• W4285740371 creator A5067520942 @default.
• W4285740371 date "2022-04-27" @default.
• W4285740371 modified "2023-09-30" @default.
• W4285740371 title "Efficacy of Apatinib plus S-1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines" @default.
• W4285740371 cites W2963555794 @default.
• W4285740371 cites W2973315340 @default.
• W4285740371 cites W2980050728 @default.
• W4285740371 cites W2992101590 @default.
• W4285740371 cites W2999051509 @default.
• W4285740371 cites W3011118647 @default.
• W4285740371 cites W3011755433 @default.
• W4285740371 cites W3012821548 @default.
• W4285740371 cites W3019852184 @default.
• W4285740371 cites W3021046581 @default.
• W4285740371 cites W3032571309 @default.
• W4285740371 cites W3093964219 @default.
• W4285740371 cites W3112153165 @default.
• W4285740371 cites W3136179143 @default.
• W4285740371 cites W3141710402 @default.
• W4285740371 cites W3161525867 @default.
• W4285740371 cites W3164476699 @default.
• W4285740371 cites W3165543715 @default.
• W4285740371 cites W3192431307 @default.
• W4285740371 cites W3195441296 @default.
• W4285740371 cites W3205682699 @default.
• W4285740371 doi "https://doi.org/10.1155/2022/8060026" @default.
• W4285740371 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35529932" @default.
• W4285740371 hasPublicationYear "2022" @default.
• W4285740371 type Work @default.
• W4285740371 citedByCount "2" @default.
• W4285740371 countsByYear W42857403712022 @default.
• W4285740371 countsByYear W42857403712023 @default.
• W4285740371 crossrefType "journal-article" @default.
• W4285740371 hasAuthorship W4285740371A5007068219 @default.
• W4285740371 hasAuthorship W4285740371A5017369696 @default.
• W4285740371 hasAuthorship W4285740371A5018622165 @default.
• W4285740371 hasAuthorship W4285740371A5030560925 @default.
• W4285740371 hasAuthorship W4285740371A5060750274 @default.
• W4285740371 hasAuthorship W4285740371A5067520942 @default.
• W4285740371 hasBestOaLocation W42857403711 @default.
• W4285740371 hasConcept C121608353 @default.
• W4285740371 hasConcept C126322002 @default.
• W4285740371 hasConcept C143998085 @default.
• W4285740371 hasConcept C197934379 @default.
• W4285740371 hasConcept C2776999253 @default.
• W4285740371 hasConcept C2777299880 @default.
• W4285740371 hasConcept C2777387746 @default.
• W4285740371 hasConcept C2780668389 @default.
• W4285740371 hasConcept C2781413609 @default.
• W4285740371 hasConcept C71924100 @default.
• W4285740371 hasConcept C90924648 @default.
• W4285740371 hasConceptScore W4285740371C121608353 @default.
• W4285740371 hasConceptScore W4285740371C126322002 @default.
• W4285740371 hasConceptScore W4285740371C143998085 @default.
• W4285740371 hasConceptScore W4285740371C197934379 @default.
• W4285740371 hasConceptScore W4285740371C2776999253 @default.
• W4285740371 hasConceptScore W4285740371C2777299880 @default.
• W4285740371 hasConceptScore W4285740371C2777387746 @default.
• W4285740371 hasConceptScore W4285740371C2780668389 @default.
• W4285740371 hasConceptScore W4285740371C2781413609 @default.
• W4285740371 hasConceptScore W4285740371C71924100 @default.
• W4285740371 hasConceptScore W4285740371C90924648 @default.
• W4285740371 hasLocation W42857403711 @default.
• W4285740371 hasLocation W42857403712 @default.
• W4285740371 hasLocation W42857403713 @default.
• W4285740371 hasLocation W42857403714 @default.
• W4285740371 hasOpenAccess W4285740371 @default.
• W4285740371 hasPrimaryLocation W42857403711 @default.
• W4285740371 hasRelatedWork W2005022537 @default.
• W4285740371 hasRelatedWork W2378684045 @default.
• W4285740371 hasRelatedWork W2937409660 @default.
• W4285740371 hasRelatedWork W3015767158 @default.
• W4285740371 hasRelatedWork W3030995811 @default.
• W4285740371 hasRelatedWork W3046280580 @default.
• W4285740371 hasRelatedWork W3150712416 @default.
• W4285740371 hasRelatedWork W3181149179 @default.
• W4285740371 hasRelatedWork W4283784692 @default.
• W4285740371 hasRelatedWork W4287073605 @default.
• W4285740371 hasVolume "2022" @default.
• W4285740371 isParatext "false" @default.
• W4285740371 isRetracted "false" @default.
• W4285740371 workType "article" @default.